Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXDX | ARWR | AXSM | ||
| Company | Prometheus Biosciences Inc | Arrowhead Pharma | Axsome Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 199.68 | 71.25 | 184.28 | ||
| High | 199.98 | 73.25 | 187.13 | ||
| Low | 199.60 | 69.15 | 183.86 | ||
| Latest | 199.92 | 72.97 | 214.71 | ||
| Change | +0.18 | +2.44 | +30.76 | ||
| % Change | +0.09% | +3.46% | +16.72% | ||
| Volume | 1,860,600 | 507,303 | 343,813 | ||
| 20-Day Average Volume | 1,174,595 | 1,739,489 | 600,093 | ||
| Previous Close | 199.74 | 70.53 | 183.95 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 198.02 | 68.39 | 181.33 | ||
| 20-Day Raw Stochastic | 99.23% | 79.66% | 74.79% | ||
| 20-Day Relative Strength | 81.45 | 61.08 | 59.39 | ||
| Weighted Alpha | +110.70 | +283.63 | +71.60 | ||
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 48% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.47% since 06/08/23 | -1.92% since 04/23/26 | +1.99% since 04/23/26 | ||
| Low | 198.91 on 06/09/23 | 68.97 on 04/29/26 | 180.00 on 04/29/26 | ||
| High | 199.98 on 06/15/23 | 75.32 on 04/24/26 | 193.49 on 04/27/26 | ||
| 1-Month | |||||
| %Chg | +2.82% since 05/15/23 | +26.58% since 03/30/26 | +16.11% since 03/30/26 | ||
| Low | 189.76 on 05/16/23 | 58.65 on 03/31/26 | 159.92 on 03/31/26 | ||
| High | 199.98 on 06/15/23 | 76.48 on 04/23/26 | 193.49 on 04/27/26 | ||
| 3-Month | |||||
| %Chg | +72.97% since 03/15/23 | +5.26% since 01/30/26 | +1.14% since 01/30/26 | ||
| Low | 104.55 on 03/30/23 | 54.02 on 03/13/26 | 152.28 on 03/24/26 | ||
| High | 199.98 on 06/15/23 | 76.48 on 04/23/26 | 193.49 on 04/27/26 | ||
| 6-Month | |||||
| %Chg | +85.68% since 12/15/22 | +72.48% since 10/30/25 | +39.95% since 10/30/25 | ||
| Low | 103.33 on 01/06/23 | 37.06 on 11/20/25 | 123.50 on 11/03/25 | ||
| High | 199.98 on 06/15/23 | 76.76 on 01/06/26 | 193.49 on 04/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,558,772 | 9,876,456 | 9,462,386 | ||
| Shares Outstanding, K | 47,813 | 140,032 | 51,440 | ||
| Annual Sales | 6,810,000 | 829,450,000 | 638,500,000 | ||
| Annual Net Income | -141,750,000 | -1,630,000 | -183,170,000 | ||
| Last Quarter Sales | 1,110,000 | 264,030,000 | 196,000,000 | ||
| Last Quarter Net Income | -40,880,000 | 30,810,000 | -28,560,000 | ||
| 60-Month Beta | -0.49 | 1.26 | 0.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.86 on 05/09/23 | 0.22 on 02/05/26 | -0.71 on 02/23/26 | ||
| Earnings Date | 08/10/23 | 05/07/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 45.84 | 0.00 | ||